1. Tomas J. Philipson & Anupam B. Jena, 2005. "Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs," NBER Working Papers 11810, National Bureau of Economic Research, Inc. [Downloadable!] (restricted)
2. B. Brüggenjürgen & P. Lindgren & B. Ehlken & H.-J. Rupprecht & S. Willich, 2007. "Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany," The European Journal of Health Economics, Springer, vol. 8(1), pages 51-57, March. [Downloadable!] (restricted)
3. Jérôme Foncel & Nicolas Treich, 2005. "Fear of Ruin," Journal of Risk and Uncertainty, Springer, vol. 31(3), pages 289-300, December. [Downloadable!] (restricted)
4. J. Kirsch & A. McGuire, 2000. "Establishing health state valuations for disease specific states: an example from heart disease," Health Economics, John Wiley & Sons, Ltd., vol. 9(2), pages 149-158.
5. Don Kenkel, 2006. "WTP- and QALY-Based Approaches to Valuing Health for Policy: Common Ground and Disputed Territory," Environmental & Resource Economics, European Association of Environmental and Resource Economists, vol. 34(3), pages 419-437, July. [Downloadable!] (restricted)
6. Werner B.F. Brouwer & Frans F.H. Rutten, 2003. "The missing link: on the line between C and E," Health Economics, John Wiley & Sons, Ltd., vol. 12(8), pages 629-636. [Downloadable!]
7. Ruth Etzioni & Scott D. Ramsey & Kristin Berry & Martin Brown, 2001. "The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study," Health Economics, John Wiley & Sons, Ltd., vol. 10(3), pages 245-256. [Downloadable!]
8. K. Claxton & P. J. Neumannn & S. S. Araki & M. C. Weinstein, . "Bayesian Value-of-Information Analysis: An Application to a Policy Model of Alzheimer's Disease," Discussion Papers 00/39, Department of Economics, University of York. [Downloadable!]
9. Elamin H. Elbasha, 2005. "Risk aversion and uncertainty in cost-effectiveness analysis: the expected-utility, moment-generating function approach," Health Economics, John Wiley & Sons, Ltd., vol. 14(5), pages 457-470. [Downloadable!]
10. Glenn Jenkins & CHUN-YAN KUO & JOHN GIRALDEZ, 2007. "Canadian Regulatory Cost-Benefit Analysis Guide," Development Discussion Papers 2007-3, JDI Executive Programs. [Downloadable!]
11. Braden Manns & David Meltzer & Ken Taub & Cam Donaldson, 2003. "Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care," Health Economics, John Wiley & Sons, Ltd., vol. 12(11), pages 949-958. [Downloadable!]
12. Philippe Beutels, 2001. "Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000)," Health Economics, John Wiley & Sons, Ltd., vol. 10(8), pages 751-774. [Downloadable!]
13. Pieter H. M. van Baal & Talitha L. Feenstra & Rudolf T. Hoogenveen & G. Ardine de Wit & Werner B. F. Brouwer, 2007. "Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio," Health Economics, John Wiley & Sons, Ltd., vol. 16(4), pages 421-433. [Downloadable!]
14. B. O. Hansen & Jens Leth Hougaard & Hans Keiding & L. P. Østerdal, 2002. "On the possibility of a bridge between CBA and CEA: Comments on a paper by Dolan and Edlin," Discussion Papers 02-21, University of Copenhagen. Department of Economics. [Downloadable!]
    Other versions:
    • Hansen, B. O. & Hougaard, J. L. & Keiding, H. & Osterdal, L. P., 2004. "On the possibility of a bridge between CBA and CEA: comments on a paper by Dolan and Edlin," Journal of Health Economics, Elsevier, vol. 23(5), pages 887-898, September. [Downloadable!] (restricted)
15. Hoel, Michael, 2009. "Efficient use of health care resources: The interaction between improved health and reduced health related income loss," HERO On line Working Paper Series 2001:9, Oslo University, Health Economics Research Programme. [Downloadable!]
16. Joshua Graff Zivin, 2001. "Cost-effectiveness analysis with risk aversion," Health Economics, John Wiley & Sons, Ltd., vol. 10(6), pages 499-508. [Downloadable!]
17. Tomas J. Philipson & Anupam B. Jena, 2006. "Surplus Appropriation from R&D and Health Care Technology Assessment Procedures," NBER Working Papers 12016, National Bureau of Economic Research, Inc. [Downloadable!] (restricted)
    Other versions:
    • Tomas J. Philipson & Anupam B. Jena, 2005. "Surplus Appropriation from R&D and Health Care Technology Assessment Procedures," Public Economics 0511021, EconWPA. [Downloadable!]
18. Hoel, Michael, 2009. "Allocating health care resources when people are risk averse with respect to life time," HERO On line Working Paper Series 2001:10, Oslo University, Health Economics Research Programme. [Downloadable!]
19. Thomas Klose, 2003. "A utility-theoretic model for QALYs and willingness to pay," Health Economics, John Wiley & Sons, Ltd., vol. 12(1), pages 17-31. [Downloadable!]
20. Mira Johri & Laura J. Damschroder & Brian J. Zikmund-Fisher & Peter A. Ubel, 2005. "The importance of age in allocating health care resources: does intervention-type matter?," Health Economics, John Wiley & Sons, Ltd., vol. 14(7), pages 669-678. [Downloadable!]
21. Helen Mason & Michael Jones-Lee & Cam Donaldson, 2009. "Modelling the monetary value of a QALY: a new approach based on UK data," Health Economics, John Wiley & Sons, Ltd., vol. 18(8), pages 933-950. [Downloadable!]
22. Liqun Liu & Andrew J. Rettenmaier & Thomas R. Saving, 2008. "Longevity bias in cost-effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 17(4), pages 523-534. [Downloadable!]
23. Mark Sculpher & David Torgerson & Ron Goeree & Bernie O'Brien, 1999. "A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis," Working Papers 169chedp, Centre for Health Economics, University of York. [Downloadable!]
24. Elamin H. Elbasha & Mark L. Messonnier, 2004. "Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale," Health Economics, John Wiley & Sons, Ltd., vol. 13(1), pages 21-35. [Downloadable!]
25. Richard H. Chapman & Marc Berger & Milton C. Weinstein & Jane C. Weeks & Sue Goldie & Peter J. Neumann, 2004. "When does quality-adjusting life-years matter in cost-effectiveness analysis?," Health Economics, John Wiley & Sons, Ltd., vol. 13(5), pages 429-436. [Downloadable!]
26. Bengt Liljas & Göran S. Karlsson & Nils-Olov Stålhammar, 2008. "On future non-medical costs in economic evaluations," Health Economics, John Wiley & Sons, Ltd., vol. 17(5), pages 579-591. [Downloadable!]
27. John A. Nyman, 2004. "Should the consumption of survivors be included as a cost in cost-utility analysis?," Health Economics, John Wiley & Sons, Ltd., vol. 13(5), pages 417-427. [Downloadable!]
28. P. Pedram Sendi & Andrew H. Briggs, 2001. "Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane," Health Economics, John Wiley & Sons, Ltd., vol. 10(7), pages 675-680. [Downloadable!]
29. Alan M. Garber, 1999. "Advances in Cost-Effectiveness Analysis of Health Interventions," NBER Working Papers 7198, National Bureau of Economic Research, Inc. [Downloadable!] (restricted)
30. Davide Consoli & Andrea Mina, 2009. "An evolutionary perspective on health innovation systems," Journal of Evolutionary Economics, Springer, vol. 19(2), pages 297-319, April. [Downloadable!] (restricted)
31. F. Barigozzi, 2001. "Reimbursing Preventive Care," Working Papers 403, Dipartimento Scienze Economiche, Universita' di Bologna. [Downloadable!]
    Other versions:
    • Francesca Barigozzi, 2004. "Reimbursing Preventive Care," The Geneva Risk and Insurance Review, Palgrave Macmillan Journals, vol. 29(2), pages 165-186, December. [Downloadable!] (restricted)
    • Francesca Barigozzi, 2004. "Reimbursing Preventive Care," The Geneva Papers on Risk and Insurance Theory, Springer, vol. 29(2), pages 165-186, December. [Downloadable!]
32. Lori J. Curtis & Martin D. Dooley & Ellen L. Lipman & David H. Feeny, 2001. "The role of permanent income and family structure in the determination of child health in Canada," Health Economics, John Wiley & Sons, Ltd., vol. 10(4), pages 287-302. [Downloadable!]
33. Anupam Jena & Tomas Philipson, 2009. "Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption," NBER Working Papers 15032, National Bureau of Economic Research, Inc. [Downloadable!] (restricted)
34. Simon, Nathalie B. & Cropper, Maureen L. & Alberini, Anna & Arora, Seema, 1999. "Valuing mortality reductions in India : a study of compensating wage differentials," Policy Research Working Paper Series 2078, The World Bank. [Downloadable!]
35. David M. Cutler & Louise Sheiner, 1998. "Demographics and Medical Care Spending: Standard and Non-Standard Effects," NBER Working Papers 6866, National Bureau of Economic Research, Inc. [Downloadable!] (restricted)
    Other versions:
    • David M. Cutler & Louise Sheiner, 1999. "Demographics and medical care spending: standard and non-standard effects," Finance and Economics Discussion Series 1999-20, Board of Governors of the Federal Reserve System (U.S.). [Downloadable!]
36. Alan M. Garber & Jonathan Skinner, 2008. "Is American Health Care Uniquely Inefficient?," NBER Working Papers 14257, National Bureau of Economic Research, Inc. [Downloadable!] (restricted)
    Other versions:
    • Alan M. Garber & Jonathan Skinner, 2008. "Is American Health Care Uniquely Inefficient?," Journal of Economic Perspectives, American Economic Association, vol. 22(4), pages 27-50, Fall.
37. Karl Claxton & Mark Sculpher & Anthony Culyer & Chris McCabe & Andrew Briggs & Ron Akehurst & Martin Buxton & John Brazier, 2006. "Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion," Health Economics, John Wiley & Sons, Ltd., vol. 15(1), pages 1-4. [Downloadable!]
38. Michael Grossman, 1999. "The Human Capital Model of the Demand for Health," NBER Working Papers 7078, National Bureau of Economic Research, Inc. [Downloadable!] (restricted)

This page was last updated on 2009-12-30.